Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-22

Study Completion Date

2020-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quantitative evaluation of the breast's morphological variations during radiotherapy consisting in performing three-dimensional surface acquisitions of the breast in order to study its shape and volume. Evaluation of the dosimetric impact of these variations.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Deformable Image Registration for Breast Adaptive Tomotherapy

NCT05383144

Breast Cancer

COMPLETED

Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer

NCT03580837

Breast Cancer

UNKNOWN

MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer

NCT03863301

Breast Cancer

WITHDRAWN PHASE2

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

NCT04902937

Tumor Cell, Circulating

RECRUITING

Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer

NCT02316561

Breast Neoplasm

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Female Adjuvant Radiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

observational cohort

Group Type EXPERIMENTAL

3D surface scan

Intervention Type DEVICE

measurement of inter fractional deformations by surface scanning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3D surface scan

measurement of inter fractional deformations by surface scanning

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* In situ or invasive breast carcinoma
* Treated by conservative breast surgery
* Pre-treatment with authorized chemotherapy
* Eligible for conventional breast irradiation in 25 sessions of 2 Gy with or without irradiation of the tumor bed and lymph nodes area
* Conventional 3D radiotherapy technique
* Bra cup size from A to D included
* Speaking and understanding french
* Having given written consent
* Patient with health insurance

Exclusion Criteria

* Surgical treatment by mastectomy
* No indication for breast radiotherapy
* Local or diffuse inflammatory state of the breast at inclusion
* History of epilepsy or anticonvulsive treatment for preventive or curative purposes
* BMI\> 30kg / m2
* T4 stage tumor
* Bilateral breast tumor
* Use of a ventilatory control to treat the patient
* Minor patient or major incompetent
* Patient deprived of liberty
* Patient under safeguard of justice

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No